Notable exceptions were t(1;19) (TCF3-PBX1) rearranged leukemias, in which iberdomide-induced IKZF1 loss led to opposite effects, causing resistance to GCs (Supplementary Figure 5). The gene discussed is PBX1; the disease is leukemia.